Agilent Technologies Completes Acquisition of ProZyme
SANTA CLARA, Calif.–(BUSINESS WIRE)–Aug. 1, 2018– Agilent Technologies, Inc. (NYSE:A) today announced that it has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. Founded in 1990, Hayward-Calif. based ProZyme is an industry leading developer and manufacturer of glycan reagents, kits... Read more